Iobenguane: Difference between revisions
Jump to navigation
Jump to search
m Protected "Iobenguane": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
Line 33: | Line 33: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Radiopharmaceuticals}} | {{Radiopharmaceuticals}} |
Latest revision as of 18:40, 4 September 2012
File:Iobenguane.svg | |
Clinical data | |
---|---|
Synonyms | meta-iodobenzylguanidine mIBG, MIBG |
Routes of administration | Intravenous |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C8H10IN3 |
Molar mass | 275.09 g/mol |
Iobenguane, also known as metaiodobenzylguanidine or mIBG, is a radiopharmaceutical.[1] It is a radiolabeled molecule similar to norepinephrine.
The isotope of iodine used can be Iodine-123 or Iodine-131.
It can be used to identify the location of certain types of tumors.[2]
References
- ↑ "Iobenguane I 131 Sulfate (Intravenous Route) - MayoClinic.com". Retrieved 2007-12-15.
- ↑ Scarsbrook AF, Ganeshan A, Statham J; et al. (2007). "Anatomic and functional imaging of metastatic carcinoid tumors". Radiographics. 27 (2): 455–77. doi:10.1148/rg.272065058. PMID 17374863.
Categories:
- Pages with script errors
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Organoiodides
- Radiopharmaceuticals